Dave Singh
Researcher Next ID · RN-032858
Researcher · Medicine
Manchester, Canada
- Works count
- 1,040
- Citation count
- 39,857
- H-index
- 89
- i10-index
- 409
Research interests
Publications
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary
European Respiratory Journal · 2023 · https://doi.org/10.1183/13993003.00239-2023
Air pollution and COPD: GOLD 2023 committee report
European Respiratory Journal · 2023 · https://doi.org/10.1183/13993003.02469-2022
Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review
American Journal of Respiratory and Critical Care Medicine · 2022 · https://doi.org/10.1164/rccm.202201-0209pp
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
The Lancet Respiratory Medicine · 2020 · https://doi.org/10.1016/s2213-2600(20)30511-7
Inflammatory Endotype–associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis
American Journal of Respiratory and Critical Care Medicine · 2020 · https://doi.org/10.1164/rccm.202009-3448oc
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine · 2020 · https://doi.org/10.1164/rccm.202009-3533so
Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective
European Respiratory Journal · 2020 · https://doi.org/10.1183/13993003.01009-2020
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease
American Journal of Respiratory and Critical Care Medicine · 2020 · https://doi.org/10.1164/rccm.201911-2207oc
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study
The Lancet Respiratory Medicine · 2019 · https://doi.org/10.1016/s2213-2600(19)30049-9
Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial
The Lancet Respiratory Medicine · 2019 · https://doi.org/10.1016/s2213-2600(19)30190-0
Benralizumab for the Prevention of COPD Exacerbations
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1905248
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019
European Respiratory Journal · 2019 · https://doi.org/10.1183/13993003.00164-2019
Chronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation
American Journal of Respiratory and Critical Care Medicine · 2018 · https://doi.org/10.1164/rccm.201810-1860so
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD
New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1713901
Informe 2017 de la Iniciativa Global para el Diagnóstico, Tratamiento y Prevención de la Enfermedad Pulmonar Obstructiva Crónica: Resumen Ejecutivo de GOLD
Archivos de Bronconeumología · 2017 · https://doi.org/10.1016/j.arbres.2017.02.001
LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
International Journal of COPD · 2017 · https://doi.org/10.2147/copd.s130482
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report
Respirology · 2017 · https://doi.org/10.1111/resp.13012
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
American Journal of Respiratory and Critical Care Medicine · 2017 · https://doi.org/10.1164/rccm.201701-0218pp
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary
European Respiratory Journal · 2017 · https://doi.org/10.1183/13993003.00214-2017
Eosinophilic inflammation in COPD: prevalence and clinical characteristics
European Respiratory Journal · 2014 · https://doi.org/10.1183/09031936.00162414
Current projects
No projects listed.